Health decisions are rarely black and white.

And for millions of women navigating menopause, one of the most controversial tools in the toolkit—hormone therapy (HRT)—just made headlines again.

A new expert panel convened by the FDA is recommending the removal of the black box warning that appears on all estrogen-containing menopause treatments.

This stark warning, which has long cautioned against risks of stroke, dementia, breast cancer, and blood clots, may soon disappear—at least on some forms of HRT.

So, should you be concerned? Or relieved?

Let’s be honest: The black box warning, first slapped on these therapies in 2003, scared off a generation of women. It was based on early results from the Women’s Health Initiative study, which linked HRT to increased risk of serious conditions.

But that study had flaws—including the fact that most participants were well past menopause when treatment began.

Since then, newer analyses (some by the original study authors) have challenged those conclusions. They’ve shown that when HRT is started before age 60 or within 10 years of menopause onset, the benefits may outweigh the risks—especially when it comes to heart health, bone strength, and quality of life.

And yet… this issue isn’t simple.

While e-Alert and the Health Sciences Institute (HIS) have long supported the safe, informed use of hormone therapy—we also believe you deserve every piece of information before making a decision about your body.

That means understanding:

  • What kind of therapy you’re using (systemic vs. localized)
  • How it’s delivered (pill, patch, cream)
  • Your personal health history
  • And yes, the potential risks and interactions with other medications

You shouldn’t be handed a prescription without all the facts. And you definitely shouldn’t be pressured to take—or not take—something based on outdated data or fear.

This panel’s recommendation is a step in the right direction. It signals a growing acknowledgment that nuance matters, and that hormone therapy isn’t one-size-fits-all.

Here’s what you can do now:

  • Talk to a certified menopause specialist (The Menopause Society has a provider database)
  • Ask about different HRT options, especially if you’re using vaginal estrogen for dryness or discomfort—these low-dose forms may carry very different risks
  • Make sure your doctor knows your full health history before prescribing anything

At the end of the day, you are your best advocate. And we’re here to help you stay informed, confident, and in control of your health.

To making decisions on your terms,

Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team

P.S. If you missed it, be sure to check out the July issue of Health Sciences Institute. We dive deeper into the history—and the future—of hormone therapy for women, including why one expert says it’s time to forget everything you’ve been told about estrogen. Don’t miss it! Click here to read more.

Sources:

Hetter, K. (2025, July 24). Black box warning on menopause hormone therapies should be removed, experts say. CNN. https://www.cnn.com/2025/07/24/health/menopause-hormone-treatment-wellness


Recent Articles:

Allan Spreen, M.D.
Dr. Allan Spreen, Chief Medical Advisor

Meet the Health Sciences Institute

The Health Sciences Institute (HSI) is an independent organization established in 1998. We’re dedicated to uncovering and researching the most urgent advances in modern underground medicine. Things you WON’T hear about in the mainstream.

Whether they come from a laboratory in Malaysia, a clinic in South America, or a university in Germany, our goal is to bring the treatments that work directly to the people who need them. We alert our Members to exciting breakthroughs in medicine, show them exactly where to go to learn more, and help them understand how they and their families can benefit from these powerful discoveries.

Learn More About the Health Sciences Institute. >